These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 22835008

  • 1. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
    Delaney G, Dawe KL, Hogan R, Hunjan T, Roper J, Hazell G, Lolait SJ, Fulford AJ.
    J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
    [Abstract] [Full Text] [Related]

  • 2. Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.
    Leggett JD, Dawe KL, Jessop DS, Fulford AJ.
    J Neuroendocrinol; 2009 Nov; 21(11):888-97. PubMed ID: 19732291
    [Abstract] [Full Text] [Related]

  • 3. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 4. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y, Simpson-Durand CD, Standifer KM.
    Br J Pharmacol; 2015 Jan 15; 172(2):571-82. PubMed ID: 24666365
    [Abstract] [Full Text] [Related]

  • 5. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
    Leggett JD, Jessop DS, Fulford AJ.
    Neuroscience; 2007 Jul 13; 147(3):757-64. PubMed ID: 17574767
    [Abstract] [Full Text] [Related]

  • 6. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar 13; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 7. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC, Calo' G.
    Pharmacol Ther; 2013 Oct 13; 140(1):10-25. PubMed ID: 23711793
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.
    Okuda-Ashitaka E, Minami T, Matsumura S, Takeshima H, Reinscheid RK, Civelli O, Ito S.
    Eur J Neurosci; 2006 Feb 13; 23(4):995-1004. PubMed ID: 16519664
    [Abstract] [Full Text] [Related]

  • 10. Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats.
    Agostini S, Eutamene H, Broccardo M, Improta G, Petrella C, Theodorou V, Bueno L.
    Pain; 2009 Feb 13; 141(3):292-299. PubMed ID: 19147291
    [Abstract] [Full Text] [Related]

  • 11. Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats.
    Rodi D, Polidori C, Bregola G, Zucchini S, Simonato M, Massi M.
    Brain Res; 2002 Dec 13; 957(2):354-61. PubMed ID: 12445978
    [Abstract] [Full Text] [Related]

  • 12. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
    Sinchak K, Romeo HE, Micevych PE.
    J Comp Neurol; 2006 May 10; 496(2):252-68. PubMed ID: 16538678
    [Abstract] [Full Text] [Related]

  • 13. Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
    Gavioli EC, de Medeiros IU, Monteiro MC, Calo G, Romão PR.
    Vitam Horm; 2015 May 10; 97():241-66. PubMed ID: 25677775
    [Abstract] [Full Text] [Related]

  • 14. Central nociceptin/orphanin FQ system elevates food consumption by both increasing energy intake and reducing aversive responsiveness.
    Olszewski PK, Grace MK, Fard SS, Le Grevès M, Klockars A, Massi M, Schiöth HB, Levine AS.
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug 10; 299(2):R655-63. PubMed ID: 20427724
    [Abstract] [Full Text] [Related]

  • 15. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
    Muratani T, Minami T, Enomoto U, Sakai M, Okuda-Ashitaka E, Kiyokane K, Mori H, Ito S.
    J Pharmacol Exp Ther; 2002 Oct 10; 303(1):424-30. PubMed ID: 12235279
    [Abstract] [Full Text] [Related]

  • 16. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance.
    Ulugol A, Topuz RD, Gunduz O, Kizilay G, Karadag HC.
    Fundam Clin Pharmacol; 2016 Dec 10; 30(6):537-548. PubMed ID: 27371029
    [Abstract] [Full Text] [Related]

  • 17. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
    Rawls SM, Schroeder JA, Ding Z, Rodriguez T, Zaveri N.
    Neuropeptides; 2007 Aug 10; 41(4):239-47. PubMed ID: 17512052
    [Abstract] [Full Text] [Related]

  • 18. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.
    Bregola G, Zucchini S, Rodi D, Binaschi A, D'Addario C, Landuzzi D, Reinscheid R, Candeletti S, Romualdi P, Simonato M.
    J Neurosci; 2002 Nov 15; 22(22):10030-8. PubMed ID: 12427860
    [Abstract] [Full Text] [Related]

  • 19. Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress.
    Gavioli EC, Holanda VAD, Calo G, Ruzza C.
    Peptides; 2021 Jul 15; 141():170548. PubMed ID: 33862163
    [Abstract] [Full Text] [Related]

  • 20. Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors.
    Ciccocioppo R, de Guglielmo G, Hansson AC, Ubaldi M, Kallupi M, Cruz MT, Oleata CS, Heilig M, Roberto M.
    J Neurosci; 2014 Jan 08; 34(2):363-72. PubMed ID: 24403138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.